Literature DB >> 18280067

Strategies to maximize the encapsulation efficiency of phenylalanine ammonia lyase in microcapsules.

Ruchi M Shah1, Anil P D'mello.   

Abstract

The activity of phenylalanine ammonia lyase (PAL) encapsulated in cellulose nitrate microcapsules is only 23% of the activity of PAL in Tris buffer. This lower activity is partially due to its incomplete encapsulation. The objective of the study was to maximize the encapsulation efficiency (EE) of PAL by optimizing different formulation parameters. PAL was purified using size exclusion chromatography and then radioiodinated using the Iodo-gen reaction. Use of (125)I-PAL showed that PAL had an EE of 45% in cellulose nitrate microcapsules. Formulation parameters including concentration of polymer in solution, stirring speed and ratio of aqueous phase volume to organic phase volume were individually optimized to maximize the EE of PAL. The reformulated microcapsules showed an EE of PAL of 80%. The dramatic increase in EE was reflected in a marked (119%) increase in the activity of encapsulated PAL compared to its activity in the original microcapsules. Eighty two percent of the encapsulated PAL was physically present in the aqueous core while 18% was entrapped in the microcapsule membrane. Distribution of PAL activity in the microcapsule was in concordance with its physical distribution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280067     DOI: 10.1016/j.ijpharm.2007.12.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

2.  Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria.

Authors:  Tse Siang Kang; Lin Wang; Christineh N Sarkissian; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

3.  Structural and biochemical characterization of the therapeutic Anabaena variabilis phenylalanine ammonia lyase.

Authors:  Lin Wang; Alejandra Gamez; Holly Archer; Enrique E Abola; Christineh N Sarkissian; Paul Fitzpatrick; Dan Wendt; Yanhong Zhang; Michel Vellard; Joshua Bliesath; Sean M Bell; Jeffrey F Lemontt; Charles R Scriver; Raymond C Stevens
Journal:  J Mol Biol       Date:  2008-05-17       Impact factor: 5.469

Review 4.  Phenylketonuria: a review of current and future treatments.

Authors:  Naz Al Hafid; John Christodoulou
Journal:  Transl Pediatr       Date:  2015-10

5.  The effectiveness of plant hydrocolloids at maintaining the quality characteristics of the encapsulated form of L-phenylalanine-ammonia-lyase.

Authors:  Olga Babich; Lyubov Dyshlyuk; Svetlana Noskova; Alexander Prosekov; Svetlana Ivanova; Valery Pavsky
Journal:  Heliyon       Date:  2019-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.